This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview

This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

Comprehensive Review of Electrodiagnostic Medicine and Neuromuscular Disorders It's 2017: Save 17%!

Comprehensive Review of Electrodiagnostic Medicine and Neuromuscular Disorders

This course carries a fee of $1033.35
For more information and to purchase the course, SIGN IN or REGISTER FOR FREE

Format

Board Review

Time to Complete

31.50 hours

Released

March 1, 2014

Expires

March 1, 2017

Maximum Credits

31.50 / AMA PRA Category 1 CreditsTM

Accredited Provider




This program is provided by Oakstone Publishing, LLC.

Producer

This program is produced by Oakstone Publishing, LLC.

Program Description

Led by Program Directors Anthony A. Amato, MD, and William S. David, MD, PhD, authoritative faculty of Comprehensive Review of Electrodiagnostic Medicine and Neuromuscular Disorders will help you to better:

  • Diagnose and manage common neuromuscular problems, including motor neuron disease, peripheral neuropathies, neuromuscular junction disorders, and myopathies
  • Understand when to order specific laboratory and genetic tests, muscle and nerve biopsies, and recognize the prevalence of ordering unnecessary tests for patients with acquired and hereditary peripheral neuropathy
  • Diagnose late-onset Pompe disease, and manage the condition with the only medication approved by the FDA

Together, the faculty of this CME program will help practicing neurologists and physiatrists improve their use of EMG, nerve conduction studies, and other highly specialized studies.

Intended Audience

This activity is primarily intended for practicing neurologists and psychiatrists as well as residents and fellows in Neurology and Physical Medicine and Rehabilitation.

Educational Objectives

Upon completion of this activity, the participant will be able to:

  • Perform a thorough history and neurological exam in order to recognize common and uncommon neuromuscular diseases
  • Apply current electrodiagnostic and neuromuscular medical literature to the evaluation and management of patients with neuromuscular disorders
  • Analyze those situations regarding lab tests, electrodiagnostic studies, imaging studies, and muscle and nerve biopsies as to whether they could be necessary or unnecessary for diagnosis
  • Assess relevant treatment options
  • Develop improved competence in providing optimal care to the patient with a neuromuscular disorder
  • Predict and manage patient expectations regarding treatment options, outcomes, and prognosis

Topics and Speakers

Click here for a complete list of course topics and speakers.

Program Directors

Anthony A. Amato, MD
Vice-Chairman, Department of Neurology
Chief, Neuromuscular Division
Brigham and Women’s Hospital
Professor of Neurology
Harvard Medical School
Boston, MA
William S. David, MD, PhD
Director of EMG Laboratory and
Neuromuscular Diagnostic Center
Massachusetts General Hospital
Associate Professor of Neurology
Harvard Medical School
Boston, MA

Faculty

Anthony A. Amato, MD
Vice-Chairman, Department of Neurology, Chief
Neuromuscular Division,
Brigham and Women’s Hospital
Professor of Neurology Harvard Medical School
Boston, MA
Reports no commercial interest

David A. Chad, MD
Staff Neurologist, Massachusetts General Hospital
Associate Professor of Neurology
Harvard Medical School, Boston MA
Reports no commercial interest

Thomas I. Cochrane, MD, MBA
Associate Neurologist, Brigham and Women’s Hospital
Assistant Professor of Neurology, Harvard Medical School, Boston, MA
Reports no commercial interest

William S. David, MD, PhD
Director of EMG Laboratory and Neuromuscular Diagnostic Center
Massachusetts General Hospital
Associate Professor of Neurology
Harvard Medical School
Boston, MA
Reports no commercial interest

Vera Fridman, MD
Instructor in Neurology
Harvard Medical School
Assistant in Neurology
Massachusetts General Hospital
Boston, MA
Reports no commercial interest

Amanda C. Guidon, MD
Instructor in Neurology, Harvard Medical School
Massachusetts General Hospital, Boston, MA
Reports no commercial interest

Mohammed Kian Salajegheh
Assistant Professor of Neurology
Brigham and Women’s Hospital
Harvard Medical School, Boston, MA
Reports no commercial interest

Nutan Sharma, MD, PhD
Associate Professor of Neurology
Harvard Medical School
Associate in Neurology
Massachusetts General Hospital
Associate Neurologist
Brigham and Women’s Hospital
Boston, MA
Reports no commercial interest

Katherine B. Sims, MD
Director
Neurogenetics and Mitochondrial Disorders Clinic
Massachusetts General Hospital
Professor of Neurology
Harvard Medical School
Boston, MA
Reports no commercial interest

James D. Berry, MD, MPH
Assistant Professor of Neurology Harvard Medical School
Assistant in Neurology, Massachusetts General Hospital
Boston, MA
Research-Grants: ALS Association; Muscular Dystrophy Association, ALS Therapy Alliance, ALS Therapy Development Institute
Advisory Role: Neuraltus Pharmaceuticals, Inc
Independent Contractor: Cytokinetics, GlaxoSmithKline, Genervon Biopharmaceuticals
Material Support: Novartis

Basil T. Darras, MD
Professor of Neurology
Harvard Medical School
Associate Neurologist-in-Chief
Joseph J. Volpe Chair in Neurology
Chief, Division of Clinical Neurology Director, Neuromuscular Program
Boston Children’s Hospital, Boston, MA
Research-Grants: PTC Therapeutics, Isis Pharmaceuticals, NIH/NINDS 1U10NS077269, NIH/NIAMS 1R01AR060850, SMA Foundation, Muscular Dystrophy Association, Slaney Family Fund for SMA
Advisory Role: Isis Pharmaceuticals, Quest Diagnostics, Guidepoint Global Consultation, Easton Associates Consultation, Clearview Healthcare Partners, Gershon Lehrman Group

Erik R. Ensrud, MD
Director, Neuromuscular Center and EMG Lab
Boston VA Medical Center; Director
Neuromuscular Rehabilitation Clinic
Brigham and Women’s Hospital
Boston, MA
Advisory Role: Skulpt, Inc., FDA
Honoraria: Osler Medical

Steven A. Greenberg, MD
Associate Professor
Department of Neurology
Brigham and Women’s Hospital
Boston Children’s Hospital Informatics Program
Harvard-MIT Division of Health Sciences and Technology
Harvard Medical School, Boston, MA
S.A.G. is an inventor on intellectual property owned and managed by Brigham and Women’s Hospital

Steve S. Han, MD, PhD
Assistant in Neurology
Department of Neurology
Massachusetts General Hospital
Boston, MA
Biogen-Idec, salary as employee

Sanjeev D. Nandedkar, PhD
Senior Consultant, CareFusion
Middleton, WI
Natus Medical Inc
Employed by Natus Medical who makes EMG systems
No conflict

Sabrina Paganoni, MD, PhD
Harvard Medical School; Department of Physical Medicine and Rehabilitation Spaulding Rehabilitation Hospital Massachusetts General Hospital
Boston, MA
Research-Grants: NIH Career Development Award

CME Course Advisor
Sandy Mardant
CME Manager
smardant@oakstone.com
205-437-3058

Publishing Staff Disclosures

Oakstone Publishing, LLC has assessed conflict of interest with its faculty, authors, editors, and any individuals who were in a position to control the content of this CME activity. Any identified relevant conflicts of interest were resolved for fair balance and scientific objectivity of studies utilized in this activity. Oakstone Publishing’s planners, content reviewers, and editorial staff disclose no relevant commercial interests.

Credit

31.50

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Oakstone Publishing, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

Oakstone Publishing, LLC designates this enduring material for a maximum of 31.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclaimer

The opinions and recommendations expressed by the faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Oakstone Publishing, LLC name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

Instructions

METHOD OF PARTICIPATION: Once logged into the website, review the audio/videos, complete the comprehensive activity evaluation and score 70% or greater on the required post-test to assess the knowledge gained from reviewing the program. Once the activity and evaluation are complete and a satisfactory score is earned on the post test, you can print your CME certificate located under the certificate tab.

If you have any questions relating to the accreditation of this activity, please contact oakcmeoffice@ebix.com.

If you have any issues regarding the purchase process or getting to the course material, please contact myCME’s customer support at myCME.Support@haymarketmedical.com.

If you have any issues with the course material itself, including videos, post-tests, and credits, please contact Oakstone at oakwebmaster@ebix.com or 800-825-9806.

Refund Policy for Oakstone Products

Due to the nature of Oakstone’s product, its audio/video format and educational content, no refunds are permitted. You may return the product within 15 days of receipt and receive a credit reflective of the original price you paid for the item. This credit may be applied as payment to any product(s) produced by Oakstone Publishing, LLC. We guarantee your program against defects in materials. Simply return any defective materials, and we will replace them. To make a return, call 800-633-4743 for a Return Authorization Code. Complete the packing ticket and return with the program to 2700 Corporate Drive, Suite 100, Birmingham, AL 35242. We recommend shipping through UPS or FedEx. Return shipping fees are the responsibility of the purchaser.

System Requirements

TECHNICAL REQUIREMENTS
This site is best viewed using Internet Explorer 8 and higher, Current version of Chrome, Apple Safari 5.1.x and newer or Firefox 15.0 and newer. A broadband Internet connection is recommended. For all CME activities featuring video and/or audio you must have a sound card and speakers. To view graphic images and references that appear in separate "pop-up" windows, you must have JavaScript enabled on your computer.

COOKIE POLICY
Oakstone uses cookies and similar technologies like pixels and tags to ensure that we give you the best possible experience on our website. A cookie is a small file placed onto your device. Cookies enable us to identify your device, and enable the functioning of many features, including your ability to log into your account.
Older browsers may require the Adobe Flash Player. This browser plug-in is free, and available from the Adobe web site.

ONLINE STREAMING
Windows XP, Vista, 7 or 8 on Pc and Macintosh OS X or above on Mac computers with most current Flash player/Quicktime software and latest version of web browsers (Internet Explorer 7 or higher, Firefox 2.0 or higher, Safari 5 or higher and Chrome) for each.
Back to top